European Medicines Agency Accepts 4SC's Eligibility Request for Resminostat in Cutaneous T cell Lymphoma (CTCL)
4SC AG (4SC, FSE Prime Standard: VSC) today announced that its pre-authorisation eligibility request to the European Med…
4SC AG (4SC, FSE Prime Standard: VSC) today announced that its pre-authorisation eligibility request to the European Med…
The Bavarian Ministry of Economic Affairs is funding the formation of the Munich Accelerator Life Sciences & Medicine (M…
At the traditional BioM end-of-year dinner, this time host Prof. Horst Domdey looked back not only on an eventful year f…
At BioM's 12th BioAngels Pitch Day on December 6, promising start-ups again met potential investors. Eight selected star…
Next to the company founders, Dr. Wilhelm Kaenders (also Managing Director TOPTICA Photonics AG) and Dr. Frank Lison (Ma…
As part of this year's BioTech Bootcamp of BioM Biotech Cluster GmbH and the life science business incubator "SmiLe Incu…
The famous retailer, Lidl Ireland, and Europe’s leading provider of gift cards and prepaid solutions, epay, today announ…
The Supervisory Board of 4SC AG (4SC, FSE Prime Standard: VSC) has appointed Kathleen Masch-Wiest as a new member of the…
4SC AG (4SC, FSE Prime Standard: VSC) today provided a business update for the three months ended 30 September 2022, as…
The cluster management organizations BioM, Munich, Germany, and Osaka Bio Headquarters, Osaka, Japan, officially announc…